In our series of interviews with leading innovation and venture developers, Andrew Gaule, left, founder of the Corporate Venturing Network, talks to David Phillips, partner at SR One, GlaxoSmithKline's corporate venturing unit.

A venture firm set up as an affiliate of Taipei-listed motor company Yulon Group is among the prior backers of Epitomics.

The corporate venturing unit of Nestle backs Carl Sterrit, founder of Shield Therapeutics, one of its healthcare portfolio companies to set up another company.

Decheng Capital, a venture firm backed by an affiliate of Madrone Capital, an investment vehicle of the Walton family, which founded Walmart, backs GeneWeave.

The corporate venturing fund of the Blue Cross and Blue Shield Association backed the US-based electronic patient management system.

Mitsui-backed cancer treatment research company Boston Biomedical has sold to its strategic partner Dainippon Sumitomo Pharma, in a deal that could net up to $2.6bn.

The diagnostic testing company has pulled in $20m from investors including medical research group the Mayo Clinic.

Cancer treatment company Galera reportedly heads to $30m round with Novartis' backing.

The Intel-backed healthcare management software provider has hired John Hallock from Athenahealth as its VP of corporate communications.